http://www.sarepta.com
Sarepta Therapeutics, Inc. Company Intro
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Industry
Healthcare
Sarepta Therapeutics, Inc. Headquaters
215 First Street
Cambridge,02142
United States
Sarepta Therapeutics, Inc. Share price
17 May 2023 13:56 GMT
$149.36
0.22 (0.15 %)
Sarepta Therapeutics, Inc. Market cap
$13.726 B
WMC RANKING
2024
Sarepta Therapeutics, Inc. # 24
BiotechnologyLatest Sarepta Therapeutics, Inc. News
12 Feb 2024
Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up
Corvus Pharmaceuticals, Inc. ( CRVS Quick Quote CRVS - Free Report) announced that the FDA granted the Orphan Drug Designation to its lead pipeline...
12 Feb 2024
What's in the Cards for Medtronic (MDT) in Q3 Earnings?
Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal third-quarter performance.
12 Feb 2024
XBI Biotech ETF Attracts $161.1 Million Amid Growing Investor Interest
The SPDR S&P Biotech ETF (XBI) has gained $161.1 million in assets, signaling growing investor interest in biotech. Top holdings include BridgeBio Pharma,...
WMC Market Score
WMC Market to Revenue Score
Sarepta Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Sarepta Therapeutics, Inc. | USD | $573,356 | $1,088,252 | $-703,886 | $137,260B | 24 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Sarepta Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Post vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Sarepta Therapeutics, Inc. | 6.23 | 5.87 | 14.08 | 0 | 0 | 0 | 7.11 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
